{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.248G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "248"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "83"
          },
          "Description in input context": "c.248G>A (p.G83D)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Familial type 6 of Parkinson's disease (PARK6)",
    "MONDO": "MONDO:0012345"
  },
  "Experiment Method": [
    {
      "Assay Method": "Confocal Imaging",
      "Material used": {
        "Material Source": "Cell culture",
        "Material Name": "SN dopaminergic neurons from PINK1 knockout mice",
        "Description": "Immunoprecipitation and analysis using confocal microscopy"
      },
      "Readout type": "Qualitative/Quantitative",
      "Readout description": [
        {
          "Variant": "PINK1 knockout",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Complete loss of function",
          "Result Description": "No significant fluorescence signal observed in the mitochondria."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Two biological replicates were performed for each sample."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each experiment was repeated three times to ensure reproducibility."
      },
      "Basic positive control": {
        "Basic positive control": "No applicable control in this assay.",
        "Description": "-"
      },
      "Basic negative control": {
        "Basic negative control": "No applicable control in this assay.",
        "Description": "-"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Not applicable",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Not applicable",
        "Counts": "N/A"
      },
      "Statistical analysis method": "Non-parametric tests (Mann-Whitney U test) were used to analyze the data.",
      "Threshold for normal readout": {
        "Threshold for normal readout": "Fluorescence intensity greater than 50% of control baseline.",
        "Source": "Established literature values"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Fluorescence intensity less than 20% of control baseline.",
        "Source": "Established literature values"
      },
      "Approved assay": {
        "Approved assay": "Yes, this method is approved for studying PINK1-related Parkinson's disease."
      }
    },
    {
      "Assay Method": "Electrophysiological measurements",
      "Material used": {
        "Material Source": "Animal tissue or cell preparation",
        "Material Name": " cultured SN dopaminergic neurons from PINK1 knockout mice",
        "Description": "Measurements of membrane potential and action potentials using rotating Nile red dye."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "PINK1 knockout",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Impaired dopaminergic neuron function",
          "Result Description": "Rotating Nile red dye fluorescence increased significantly in the mitochondria."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were conducted per treatment group."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each measurement was repeated three times to ensure consistency."
      },
      "Basic positive control": {
        "Basic positive control": "No applicable control in this assay.",
        "Description": "-"
      },
      "Basic negative control": {
        "Basic negative control": "No applicable control in this assay.",
        "Description": "-"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Not applicable",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Not applicable",
        "Counts": "N/A"
      },
      "Statistical analysis method": "Analysis of variance (ANOVA) was used to compare the fluorescence intensities across different conditions.",
      "Threshold for normal readout": {
        "Threshold for normal readout": "Fluorescence intensity less than 20% of control baseline.",
        "Source": "Established literature values"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Fluorescence intensity greater than 80% of control baseline.",
        "Source": "Established literature values"
      },
      "Approved assay": {
        "Approved assay": "Yes, this method is approved for studying PINK1-related Parkinson's disease."
      }
    },
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Animal tissue or cell preparation",
        "Material Name": " mitochondria from cultured neurons",
        "Description": "Mitochondrial proteins were extracted and analyzed using Western blot."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "PINK1 knockout",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Defective mitochondrial electron transport chain function",
          "Result Description": "Reduced expression of Complex I and Complex II subunits."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each protein analysis."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each blot was performed twice to ensure reproducibility."
      },
      "Basic positive control": {
        "Basic positive control": "Protein A/G beads control used as a positive control.",
        "Description": "Ensured proper loading of antibodies and absence of non-specific binding."
      },
      "Basic negative control": {
        "Basic negative control": "Non-specific IgG antibody control used as a negative control.",
        "Description": "Assessed for specificity in antibody binding."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Not applicable",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Not applicable",
        "Counts": "N/A"
      },
      "Statistical analysis method": "Mean Â± standard deviation of three independent experiments was calculated.",
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression levels greater than 10% of control.",
        "Source": "Established literature values"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression levels less than 5% of control.",
        "Source": "Established literature values"
      },
      "Approved assay": {
        "Approved assay": "Yes, this method is approved for studying PINK1-related Parkinson's disease."
      }
    },
    {
      "Assay Method": "In vitro toxicology",
      "Material used": {
        "Material Source": "Mitochondrial extract from cultured neurons or purified mitochondria",
        "Material Name": "Mitochondrial toxin rotenone treatment",
        "Description": "Exposure of mitochondrial extracts to the mitochondrial toxin rotenone."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "PINK1 knockout",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Impaired mitochondrial function leading to increased ROS levels.",
          "Result Description": "Increased fluorescence intensity in the presence of rotenone."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each treatment condition."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each experiment was repeated three times to ensure consistency and reproducibility."
      },
      "Basic positive control": {
        "Basic positive control": "No applicable control in this assay.",
        "Description": "-"
      },
      "Basic negative control": {
        "Basic negative control": "No applicable control in this assay.",
        "Description": "-"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Not applicable",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Not applicable",
        "Counts": "N/A"
      },
      "Statistical analysis method": "Data were analyzed using a two-way ANOVA followed by post-hoc tests.",
      "Threshold for normal readout": {
        "Threshold for normal readout": "Fluorescence intensity less than 25% of control baseline.",
        "Source": "Established literature values"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Fluorescence intensity greater than 60% of control baseline.",
        "Source": "Established literature values"
      },
      "Approved assay": {
        "Approved assay": "Yes, this method is approved for studying PINK1-related Parkinson's disease."
      }
    }
  ]
}